NYSEARCA:LCTX
Lineage Cell Therapeutics, Inc. Stock News
$0.93
-0.0220 (-2.31%)
At Close: Jul 02, 2024
Lineage to Present at 2024 BIO International Convention
08:00am, Thursday, 30'th May 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium
08:00am, Tuesday, 21'st May 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Cell Therapeutics, Inc. (LCTX) Q1 2024 Earnings Call Transcript
12:33am, Friday, 10'th May 2024
Lineage Cell Therapeutics, Inc. (NYSE:LCTX ) Q1 2024 Earnings Conference Call May 9, 2024 4:30 PM ET Company Participants Ioana Hone - Head, Investor Relations Brian Culley - Chief Executive Officer J
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024
08:00am, Thursday, 02'nd May 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Announces Changes to Board of Directors
04:30pm, Monday, 29'th Apr 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX) is saddened to report the passing of its long-serving Chairman of t
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit
08:00am, Wednesday, 13'th Mar 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Cell Therapeutics, Inc. (LCTX) Q4 2023 Earnings Call Transcript
10:22pm, Thursday, 07'th Mar 2024
Lineage Cell Therapeutics, Inc. (NYSE:LCTX ) Q4 2023 Earnings Conference Call March 7, 2024 4:30 PM ET Company Participants Ioana Hone - Head of IR Brian Culley - CEO Jill Howe - CFO Conference Call P
Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
04:01pm, Thursday, 07'th Mar 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
08:00am, Tuesday, 13'th Feb 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering
09:15am, Friday, 09'th Feb 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
09:15am, Tuesday, 06'th Feb 2024
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury
08:00am, Monday, 18'th Dec 2023
CARLSBAD, Calif.--(BUSINESS WIRE)---- $LCTX #LineageCellTherapeutics--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell
3 Penny Stocks to Buy for the Next Bull Run
04:02pm, Saturday, 11'th Nov 2023
By corporate protocol and just plain old common sense, when it comes to penny stocks to buy, your first instinct should be this: don't. Yeah, I know that's not exactly a sexy opener for the topic at h